The recommended dosage of EYLEA in patients with macular edema following RVO is 2mg every four weeks. Regeneron chief scientific officer George Yancopoulos said RVO is a significant
NER1006 is a low volume polyethylene glycol based bowel preparation developed to provide whole bowel cleansing, with an additional focus on the ascending colon. The multicenter, randomized, parallel-group
The company has started this voluntary recall to the user level due to labeling the product with the incorrect expiration date, which is longer than the known stability
The FDA Office of Orphan Products Development (OOPD) mission is to advance the evaluation and development of products that show promise for the diagnosis and/or treatment of rare
As part of the deal, Lee’s Pharma will have exclusive rights to develop and commercialize the antibody for the Chinese market, including Mainland China, Hong Kong, Macau, and
The acquisition will see ClinIntel’s offerings combined into the ClinPhone RTSM suite and are designed to make patient randomization and clinical supply chain solutions more efficient. ClinIntel’s capabilities
Currently, there are no approved treatments for FA, which is a debilitating, life-shortening, degenerative neuro-muscular disorder affecting at least one in 50,000 people in the US. Most youngsters
The humanized monoclonal antibody, RPC4046 is directed against interleukin-13 (IL-13), a target which has been validated in other related allergic indications. Receptos president and chief executive officer Faheem
NKTT120 is a humanised monoclonal antibody that specifically depletes iNKT cells, a regulatory T cell that has been demonstrated as a major mediator of organ damage in preclinical
As part of the acquisition, Bayer now owns Merck’s existing over-the-counter (OTC) business, including the global trademark and prescription rights for Claritin and Afrin. Bayer has held back
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.